Table 1.
Basic clinical data for AS patients
| Patient number | 1 | 2 | 3 | 4 | 5 | 6 |
|---|---|---|---|---|---|---|
| Diagnosis | AS | AS | AS | AS | AS | AS |
| Age, in years | 43 | 39 | 35 | 41 | 37 | 26 |
| Sex (male or female) | M | F | M | M | M | M |
| BMI | 20.2 | 21.3 | 20.7 | 21.9 | 19.7 | 18.5 |
| HLA-B27 | + | + | + | + | + | + |
| BASDAI | 4.1 | 3.7 | 4.5 | 5.6 | 5.5 | 4.9 |
| NSAIDs used | Yes | Yes | Yes | Yes | Yes | Yes |
| DMARDs used | MTX + SSZ | MTX + SSZ | MTX + SSZ | MTX + SSZ | MTX + SSZ | MTX + SSZ |
| Corticosteroids used | No | No | No | No | No | No |
| TNF-blockade used | No | No | No | No | No | No |
| mSASS scores | 42 | 33 | 39 | 48 | 55 | 22 |
| New York grading | IV | IV | IV | IV | IV | IV |
Note: + is HLA-B27 positive and − is HLA-B27 negative.
Abbreviations: AS, ankylosing spondylitis; BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; DMARDs, Disease Modifying Antirheumatic Drugs; mSASS, modified Stoke Ankylosing Spondylitis Spinal Score; NY, New York; MTX, methotrexate; NSAIDs, nonsteroidal anti-inflammatory drugs; SSZ, sulfasalazine; TNF, tumor necrosis factor.